Radiopharmaceuticals: Consulting for Complex Therapies

---

Specialized guidance covering unique regulatory strategies (IND, NDA/MAA), radiation safety, CMC challenges (radionuclide handling, short half-lives), GMP compliance, clinical trial design (dosimetry), pharmacovigilance, radiation safety training, and logistics.

Navigating the regulatory landscape for radiopharmaceuticals requires a deep understanding of both pharmaceutical and radiation safety regulations. Regal Intel provides comprehensive regulatory strategy development, from preclinical planning through to market authorization. We assist with IND, NDA/MAA, and other global regulatory submissions, ensuring compliance with FDA, EMA, and other international agencies. Our services include:

• Pre-IND/Pre-MAA Meetings: Strategic planning and preparation for regulatory interactions.
• Dossier Preparation (eCTD): Expert compilation of CMC, preclinical, and clinical data.
• Radiation Dosimetry and Safety Assessments: Ensuring compliance with radiation safety requirements.
• Labeling and Packaging Compliance: Meeting specific regulatory guidelines for radiopharmaceuticals.

The manufacturing of radiopharmaceuticals involves unique challenges related to radionuclide handling, quality control, and short half-lives. Regal Intel provides expert consulting on:

• GMP Compliance for Radiopharmaceuticals: Ensuring manufacturing processes meet stringent quality standards.
• Radionuclide Sourcing and Handling: Guidance on safe and compliant handling of radioactive materials.
• Analytical Method Development and Validation: Ensuring accurate and reliable quality control testing.
• Stability Studies and Shelf-Life Determination: Addressing the unique stability challenges of radiopharmaceuticals.
• Facility Design and Radiation Safety: Consulting on facility design and implementation of radiation protection measures.

Clinical trials for radiopharmaceuticals require specialized expertise in radiation safety and patient monitoring. Regal Intel assists with:

• Clinical Trial Design and Protocol Development: Incorporating radiation safety and dosimetry considerations.
• Patient Dosimetry and Safety Monitoring: Ensuring patient safety throughout clinical trials.
• Adverse Event Reporting and Management: Addressing the unique safety profile of radiopharmaceuticals.
• Data Management and Statistical Analysis: Handling specialized data from radiopharmaceutical trials.

Maintaining ongoing safety and efficacy monitoring is crucial for radiopharmaceuticals. Regal Intel provides:

• Pharmacovigilance System Development: Tailored to the unique needs of radiopharmaceuticals.
• Adverse Event Reporting and Signal Detection: Monitoring and reporting of adverse events.
• Risk Management Plans: Developing and implementing strategies to mitigate risks.
• Post-Market Clinical Follow-up Studies: Ensuring long-term safety and efficacy.

Radiation safety is paramount in the radiopharmaceutical industry. Regal Intel offers:

• Radiation Safety Training Programs: Educating personnel on safe handling and use of radioactive materials.
• Radiation Protection Program Development: Ensuring compliance with regulatory requirements.
• ALARA (As Low As Reasonably Achievable) Implementation: Optimizing radiation protection measures.
• Facility Audits and Compliance Assessments: Ensuring radiation safety compliance.

The logistics and distribution of radiopharmaceuticals require careful planning and execution due to their short half-lives and radiation hazards. Regal Intel provides:

• Supply Chain Management: Optimizing the delivery of radiopharmaceuticals.
• Transportation and Handling Compliance: Ensuring safe and compliant transportation.
• Cold Chain Management: Maintaining product integrity throughout the distribution process.